Kate Haviland
Chief Business Officer, Blueprint Medicines Corp.
Companies
- Avalyn Pharma Inc.Board member Apr 29, 2026 to now1
- Blueprint Medicines CorpBoard member Apr 3, 2025 to now2
- Bicara Therapeutics Inc.Board member Sep 12, 2024 to now3
- Blueprint Medicines CorpChief executive officer Nov 7, 2022 to now4
- Fulcrum Therapeutics (United States)Board member Jul 17, 2019 to now5
- Blueprint Medicines CorpChief operating officer Mar 5, 2019 to Mar 8, 20226
- Blueprint Medicines CorpChief Business Officer Jan 13, 2016 to Mar 20, 20187
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Bicara Therapeutics Inc. BCAX7,437 shares8$124.8K at $16.78Sep 12, 2024
- Blueprint Medicines Corp0 shares9Jul 17, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 17, 2025U 70,729 shares of Blueprint Medicines Corp9
- Jul 17, 2025Returned to company 224,410 shares of Blueprint Medicines Corp9
- Jul 17, 2025Granted 129,210 shares of Blueprint Medicines Corp9
- Apr 1, 2025Sold 100 shares at $88.59 of Blueprint Medicines Corp10
- Apr 1, 2025Sold 1,200 shares at $87.34 of Blueprint Medicines Corp10
- Apr 1, 2025Sold 598 shares at $86.14 of Blueprint Medicines Corp10
- Apr 1, 2025Sold 600 shares at $85.47 of Blueprint Medicines Corp10
- Mar 5, 2025Sold 16,151 shares at $88.80 of Blueprint Medicines Corp11
- Mar 1, 2025Granted 35,200 shares of Blueprint Medicines Corp12
- Jan 21, 2025Sold 1,446 shares at $110.24 of Blueprint Medicines Corp13
- Nov 29, 2024Sold 207 shares at $97.76 of Blueprint Medicines Corp14
- Nov 29, 2024Sold 1,746 shares at $96.74 of Blueprint Medicines Corp14
- Nov 29, 2024Sold 400 shares at $95.40 of Blueprint Medicines Corp14
- Mar 7, 2024Sold 12,464 shares at $90.69 of Blueprint Medicines Corp15
- Mar 1, 2024Granted 40,000 shares of Blueprint Medicines Corp16
- Mar 6, 2023Sold 212 shares at $44.65 of Blueprint Medicines Corp17
- Mar 6, 2023Sold 6,428 shares at $45.72 of Blueprint Medicines Corp17
- Mar 1, 2023Granted 40,000 shares of Blueprint Medicines Corp18
- Nov 3, 2022Bought 1,100 shares at $43.98 of Blueprint Medicines Corp19
- Mar 7, 2022Sold 1,048 shares at $56.18 of Blueprint Medicines Corp20
- Mar 3, 2022Sold 1,719 shares at $60.27 of Blueprint Medicines Corp20
- Mar 1, 2022Granted 40,000 shares of Blueprint Medicines Corp21
- Dec 13, 2021Sold 94 shares at $96.78 of Blueprint Medicines Corp22
- Dec 13, 2021Sold 411 shares at $97.60 of Blueprint Medicines Corp22
- Dec 13, 2021Sold 210 shares at $98.50 of Blueprint Medicines Corp22
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAvalyn Pharma Inc., Board member
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Apr 3, 2025
- 11SEC EDGARForm 4 filed Mar 7, 2025
- 12SEC EDGARForm 4 filed Mar 4, 2025
- 13SEC EDGARForm 4 filed Jan 23, 2025
- 14SEC EDGARForm 4 filed Dec 3, 2024
- 15SEC EDGARForm 4 filed Mar 11, 2024
- 16SEC EDGARForm 4 filed Mar 6, 2024
- 17SEC EDGARForm 4 filed Mar 8, 2023
- 18SEC EDGARForm 4 filed Mar 3, 2023
- 19SEC EDGARForm 4 filed Nov 7, 2022
- 20SEC EDGARForm 4 filed Mar 8, 2022
- 21SEC EDGARForm 4 filed Mar 3, 2022
- 22SEC EDGARForm 4 filed Dec 15, 2021